Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-2016 | 11-2015 | 08-2015 | 05-2015 | 02-2015 | |
| Sales | 351 | 942 | 852 | 1,125 | 343 |
| Cost of Goods | 787 | 946 | 1,831 | 860 | 2,134 |
| Gross Profit | -436 | -4 | -979 | 265 | -1,791 |
| Operating Expenses | 3,657 | 4,752 | 8,043 | 7,015 | 6,452 |
| Operating Income | -3,306 | -3,810 | -8,191 | -5,890 | -8,109 |
| Interest Expense | 2 | 4 | -2 | 20 | 9 |
| Other Income | 2,256 | 396 | 15 | 8 | 11 |
| Pre-tax Income | -1,052 | -3,418 | -8,174 | -5,902 | -8,107 |
| Income Tax | N/A | -1 | 2 | N/A | N/A |
| Net Income Continuous | -1,052 | -3,417 | -8,176 | -5,902 | -8,107 |
| Net Income | $-1,052 | $-3,417 | $-8,176 | $-5,902 | $-8,107 |
| EPS Basic Total Ops | -0.09 | -0.39 | -1.29 | -0.98 | -1.34 |
| EPS Basic Continuous Ops | -0.09 | -0.39 | -1.26 | -0.97 | -1.34 |
| EPS Diluted Total Ops | -0.09 | -0.39 | -1.29 | -0.98 | -1.34 |
| EPS Diluted Continuous Ops | -0.09 | -0.39 | -1.26 | -0.97 | -1.34 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.39 | -1.26 | -0.98 | -1.34 |
| EBITDA(a) | $-3,209 | $-3,695 | $-8,039 | $-5,737 | $-7,946 |